White Pine Capital LLC Sells 296 Shares of Transcat, Inc. (NASDAQ:TRNS)

White Pine Capital LLC reduced its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 3.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 9,689 shares of the scientific and technical instruments company’s stock after selling 296 shares during the quarter. White Pine Capital LLC’s holdings in Transcat were worth $1,059,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Diversified Trust Co raised its holdings in Transcat by 4.3% during the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock valued at $266,000 after buying an additional 100 shares in the last quarter. Commonwealth Equity Services LLC increased its stake in shares of Transcat by 4.2% in the third quarter. Commonwealth Equity Services LLC now owns 4,377 shares of the scientific and technical instruments company’s stock worth $429,000 after purchasing an additional 175 shares during the period. Swiss National Bank increased its stake in shares of Transcat by 1.2% in the third quarter. Swiss National Bank now owns 16,815 shares of the scientific and technical instruments company’s stock worth $1,647,000 after purchasing an additional 200 shares during the period. Arizona State Retirement System increased its stake in shares of Transcat by 11.9% in the fourth quarter. Arizona State Retirement System now owns 2,434 shares of the scientific and technical instruments company’s stock worth $266,000 after purchasing an additional 258 shares during the period. Finally, Raymond James & Associates increased its stake in shares of Transcat by 6.5% in the fourth quarter. Raymond James & Associates now owns 6,384 shares of the scientific and technical instruments company’s stock worth $698,000 after purchasing an additional 387 shares during the period. 98.34% of the stock is currently owned by institutional investors.

Transcat Stock Performance

TRNS traded down $0.01 on Friday, hitting $109.83. 60,743 shares of the stock traded hands, compared to its average volume of 37,283. Transcat, Inc. has a 52 week low of $74.89 and a 52 week high of $116.19. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $969.80 million, a PE ratio of 84.49 and a beta of 0.59. The business has a fifty day moving average price of $108.73 and a two-hundred day moving average price of $102.61.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The firm had revenue of $65.17 million for the quarter, compared to analyst estimates of $63.36 million. On average, research analysts predict that Transcat, Inc. will post 1.34 EPS for the current fiscal year.

Analysts Set New Price Targets

TRNS has been the topic of a number of recent analyst reports. Oppenheimer reiterated an “outperform” rating and issued a $125.00 price objective (up from $120.00) on shares of Transcat in a research note on Thursday, April 18th. TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Finally, HC Wainwright reiterated a “buy” rating and issued a $124.00 price objective on shares of Transcat in a research note on Tuesday, April 16th.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 5,000 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $111.30, for a total transaction of $556,500.00. Following the transaction, the chief executive officer now directly owns 108,478 shares in the company, valued at $12,073,601.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of Transcat stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $111.30, for a total transaction of $556,500.00. Following the sale, the chief executive officer now directly owns 108,478 shares of the company’s stock, valued at $12,073,601.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Charles P. Hadeed sold 700 shares of Transcat stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $113.00, for a total value of $79,100.00. Following the sale, the director now directly owns 22,678 shares in the company, valued at $2,562,614. The disclosure for this sale can be found here. Insiders have sold 8,073 shares of company stock worth $900,023 over the last three months. Company insiders own 4.20% of the company’s stock.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.